HCPCS Level IIdrugActive
J0738
Hiv prep, inj, lenacapavir
BETOS: O1E
Effective: 2025-10-01
Referenced in 2 policies
Description
Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Yeztugo
Manufacturer
Gilead Sciences, Inc.
HCPCS Dosage
1 MG
Billing Units
463.5000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.